All News #Library
Biotech
Azitra to Present ATR-01 Ichthyosis Vulgaris Data at ASGCT 2026
28 Apr 2026 //
PR NEWSWIRE
Azitra Prices Private Placement Up To $31.4 M
19 Mar 2026 //
PR NEWSWIRE
Azitra Announces Full Year 2025 Results and Business Updates
27 Feb 2026 //
PR NEWSWIRE
Azitra Adds MD Anderson to ATR-04 Ph1/2 Trial
24 Feb 2026 //
PR NEWSWIRE
Azitra To Present At BIO Investment & Growth Summit
19 Feb 2026 //
PR NEWSWIRE
Azitra Adjourns Special Meeting, Sets Reconvened Meeting
07 Feb 2026 //
PR NEWSWIRE
Azitra To Present At Biotech Showcase With J.P. Morgan Conference
07 Jan 2026 //
PR NEWSWIRE
Azitra Notified Of NYSE American Listing Standards Compliance
17 Dec 2025 //
PR NEWSWIRE
Azitra Reveals Q3 2025 Results & Business Updates
13 Nov 2025 //
PR NEWSWIRE
Azitra Reveals Promising Preclinical Results For ATR-01
20 Oct 2025 //
PR NEWSWIRE
Azitra to Present at Biotech Show 2025 and J.P. Morgan Conference
20 Dec 2024 //
PR NEWSWIRE
Azitra ATR-12 Netherton Data, Design At ASGCT 2024
10 May 2024 //
BUSINESSWIRE
Azitra`s Preclinical Data At ASGCT Gene Therapy Meeting
22 Apr 2024 //
BUSINESSWIRE
Azitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024
03 Jan 2024 //
BUSINESSWIRE
Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to Board of Directors
19 Jul 2023 //
PR NEWSWIRE
A small Connecticut biotech throws hat into IPO ring
21 Feb 2023 //
ENDPTS

Market Place
Sourcing Support